Orchid Pharma Ratios and Metrics

Market cap in millions INR. Fiscal year is April - March.

Millions INR. Fiscal year is Apr - Mar.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	2015 - 2019
Period Ending	Apr '25 Apr 22, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021	Mar '20 Mar 31, 2020	2015 - 2019
Market Capitalization	42,782	52,994	15,643	11,641	98,268	-	Upgrade
Market Cap Growth	153.62%	238.77%	34.38%	-88.15%	-	-	Upgrade
Enterprise Value	41,992	53,964	18,909	14,449	102,406	-	Upgrade
Last Close Price	844.30	1045.20	384.40	284.30	2465.15	-	Upgrade
PE Ratio	38.58	57.50	33.77	-	-	-	Upgrade
PS Ratio	4.75	6.47	2.35	2.08	21.83	-	Upgrade
PB Ratio	3.49	4.53	2.27	1.80	15.05	-	Upgrade
P/TBV Ratio	3.55	4.59	2.27	1.80	15.06	-	Upgrade
P/FCF Ratio	-	86.62	-	14.91	427.59	-	Upgrade
P/OCF Ratio	-	42.06	85.30	12.59	416.64	-	Upgrade
EV/Sales Ratio	4.66	6.59	2.84	2.58	22.75	-	Upgrade
EV/EBITDA Ratio	41.93	49.33	22.57	27.21	175.38	-	Upgrade
EV/EBIT Ratio	49.23	69.52	65.22	-	-	-	Upgrade
EV/FCF Ratio	-	88.21	-	18.51	445.59	-	Upgrade
Debt / Equity Ratio	0.14	0.12	0.48	0.41	0.69	0.74	Upgrade
Debt / EBITDA Ratio	1.65	1.23	3.96	5.05	7.75	12.39	Upgrade
Debt / FCF Ratio	-	2.21	-	3.43	19.70	7.40	Upgrade
Asset Turnover	-	0.59	0.57	0.48	0.33	0.21	Upgrade
Inventory Turnover	-	2.04	2.00	2.01	1.64	1.44	Upgrade
Quick Ratio	-	0.79	0.65	0.73	1.18	0.90	Upgrade
Current Ratio	-	3.04	1.35	1.65	3.87	3.25	Upgrade
Return on Equity (ROE)	-	9.92%	7.95%	-9.29%	-13.43%	-225.00%	Upgrade
Return on Assets (ROA)	-	3.49%	1.55%	-1.80%	-2.34%	-1.99%	Upgrade
Return on Capital (ROIC)	4.02%	4.17%	1.87%	-2.10%	-2.59%	-2.34%	Upgrade
Return on Capital Employed (ROCE)	-	6.00%	3.40%	-	-	-	Upgrade
Earnings Yield	2.59%	1.74%	2.96%	-0.17%	-1.19%	-	Upgrade
FCF Yield	-	1.15%	-4.26%	6.71%	0.23%	-	Upgrade
Buyback Yield / Dilution	-10.51%	-18.49%	-	-	-9914.82%	0.15%	Upgrade

Updated Feb 12, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.